These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8701027)
1. Inhibition of adenylyl cyclase activity by the cholecystokinin analog SNF 9007 in neuroblastoma x glioma NG108-15 hybrid cells. Roerig SC; Williams CL; Hruby VJ; Burks TF; Rosenfeld GC Regul Pept; 1996 Jan; 61(1):51-6. PubMed ID: 8701027 [TBL] [Abstract][Full Text] [Related]
2. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo. Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053 [TBL] [Abstract][Full Text] [Related]
3. 7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord. Sofuoglu M; Portoghese PS; Takemori AE Life Sci; 1993; 52(8):769-75. PubMed ID: 8383271 [TBL] [Abstract][Full Text] [Related]
4. Modulation by calcium/calmodulin-dependent protein kinase II of functional response of delta opioid receptor in neuroblastoma x glioma hybrid (NG108-15) cells. Fan GH; Zhang WB; Yao CP; Pei G Neuropharmacology; 1997; 36(11-12):1763-9. PubMed ID: 9517449 [TBL] [Abstract][Full Text] [Related]
5. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes. Mattia A; Vanderah T; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835 [TBL] [Abstract][Full Text] [Related]
6. Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen. Noble F; Cox BM J Neurochem; 1995 Jul; 65(1):125-33. PubMed ID: 7790855 [TBL] [Abstract][Full Text] [Related]
7. Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro. Kramer TH; Toth G; Haaseth RC; Matsunaga TO; Davis P; Hruby VJ; Burks TF Life Sci; 1991; 48(9):881-6. PubMed ID: 1847736 [TBL] [Abstract][Full Text] [Related]
8. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens. Izenwasser S; Búzás B; Cox BM J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389 [TBL] [Abstract][Full Text] [Related]
9. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. Stewart PE; Hammond DL J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918 [TBL] [Abstract][Full Text] [Related]
10. Differential desensitization of human delta-opioid receptors by peptide and alkaloid agonists. Allouche S; Roussel M; Marie N; Jauzac P Eur J Pharmacol; 1999 Apr; 371(2-3):235-40. PubMed ID: 10357261 [TBL] [Abstract][Full Text] [Related]
11. Effects of multiple intracerebroventricular injections of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain delta-opioid receptors. Zhao GM; Bhargava HN Brain Res; 1997 Jan; 745(1-2):243-7. PubMed ID: 9037415 [TBL] [Abstract][Full Text] [Related]
12. Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain. Búzás B; Izenwasser S; Portoghese PS; Cox BM Life Sci; 1994; 54(7):PL101-6. PubMed ID: 8309345 [TBL] [Abstract][Full Text] [Related]
13. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity. Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462 [TBL] [Abstract][Full Text] [Related]
14. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363 [TBL] [Abstract][Full Text] [Related]
15. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells. Prather PL; Tsai AW; Law PY J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314 [TBL] [Abstract][Full Text] [Related]
16. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat. Thorat SN; Hammond DL J Pharmacol Exp Ther; 1997 Dec; 283(3):1185-92. PubMed ID: 9399992 [TBL] [Abstract][Full Text] [Related]
17. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice. Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H Life Sci; 1995; 57(2):155-68. PubMed ID: 7603296 [TBL] [Abstract][Full Text] [Related]
18. delta-opioid receptor mobilization of intracellular calcium in SH-SY5Y cells: lack of evidence for delta-receptor subtypes. Connor MA; Keir MJ; Henderson G Neuropharmacology; 1997 Jan; 36(1):125-33. PubMed ID: 9144649 [TBL] [Abstract][Full Text] [Related]
19. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists. Noble F; Smadja C; Roques BP J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417 [TBL] [Abstract][Full Text] [Related]
20. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]